Bridger Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-408,728
Closed -$9.91M 30
2025
Q2
$9.91M Sell
408,728
-57,331
-12% -$1.34M 5.84% 5
2025
Q1
$11.8M Hold
466,059
5.87% 5
2024
Q4
$12.4M Buy
466,059
+115,559
+33% +$3.13M 6.64% 5
2024
Q3
$10.1M Hold
350,500
5.07% 6
2024
Q2
$9.81M Hold
350,500
5.05% 6
2024
Q1
$9.73M Hold
350,500
4.38% 8
2023
Q4
$10.1M Buy
+350,500
New +$10.6M 3.87% 12

Other funds holding PFE

Bridger Management's PFE Position: Q3 2025 in Review

Bridger Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 408,728 shares — an estimated $9.91M sold.

Bridger Management first reported a position in PFE in Q4 2023 and held it in 7 quarters. The position peaked at $12.4M in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Bridger Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Bridger Management sold 408,728 Pfizer shares in Q3 2025, an estimated $9.91M.
  • Bridger Management first reported a position in Pfizer in Q4 2023 and held it in 7 quarters.
  • Bridger Management's Pfizer position peaked at $12.4M in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Bridger Management's 13F filing for Q3 2025, filed 14 Nov 2025.